Orbimed Advisors - LONGBOARD PHARMACEUTICALS IN ownership

LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 21 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of LONGBOARD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2022$422,000
+20.2%
113,5000.0%0.01%
+33.3%
Q2 2022$351,000
-42.1%
113,5000.0%0.01%
-40.0%
Q1 2022$606,000
+9.4%
113,5000.0%0.01%
+42.9%
Q4 2021$554,000
-44.8%
113,5000.0%0.01%
-36.4%
Q3 2021$1,004,000
-3.0%
113,5000.0%0.01%
+10.0%
Q2 2021$1,035,000
-78.9%
113,500
-62.2%
0.01%
-78.3%
Q1 2021$4,914,000300,0000.05%
Other shareholders
LONGBOARD PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,321,403$20,869,0000.71%
Integral Health Asset Management, LLC 30,000$274,0000.08%
FARALLON CAPITAL MANAGEMENT LLC 810,500$7,392,0000.03%
Orbimed Advisors 113,500$1,035,0000.01%
Alyeska Investment Group, L.P. 85,360$778,0000.01%
PRICE T ROWE ASSOCIATES INC /MD/ 2,287,289$20,105,0000.00%
Laurion Capital Management LP 20,918$191,0000.00%
FMR LLC 2,037,831$18,585,0000.00%
BlackRock Inc. 17,999$164,0000.00%
Tower Research Capital LLC (TRC) 38$00.00%
View complete list of LONGBOARD PHARMACEUTICALS IN shareholders